Management

25 years management in life science Industry, EVP Merckle/ratiopharm group for BD; Since 12 years CEO/COO experience in several SME, raised € 35 Mn venture funds.

Seasoned executive management member (COO, CEO) in biopharmaceuticals SME, as Axxima and U3, as well as public companies like Intercell/Valneva. Expert in kinase inhibitors, vaccines development, project management and execution.

20 years of Biotech industry, active as entrepreneur, manager, deal maker, Co-founder, CEO and CFO of CellMed AG, MD of AEterna Zentaris, 10 years Private Equity & M&A-Advisory

Board certified anesthetist with more than 15 years in industrial research and development. Senior management positions at Merck, Basilea, ICON, Otsuka in the past.

Universität D-Tübingen,Co-inventor of the technology, expert in antiviral research und translational preclinical R&D up to clinical studies. Advises the WHO on antiviral strategies against influenza.

20 years leadership positions in SMEs (Head R&D Affitech, CEO OnTarget) and big pharma (Roche, Otsuka, Abbvie). Working experiences in Europe and Asia. Background in R&D, Business Development, M&A, Financing